Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Keith A. Goldan currently holds 32,751 shares of Syndax Pharmaceuticals Inc (SNDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keith A. Goldan has been a net seller of SNDX stock. They have purchased $47.4K and sold $120.1K worth of shares.
Keith A. Goldan's most recent insider trade was on Apr 1, 2026, when they sold 32,751 shares at $0.00 per share.
Keith A. Goldan serves as Executive at Syndax Pharmaceuticals Inc (SNDX). They have executed 33 insider transactions totaling $167.6K over their tenure at the company.
Keith A. Goldan holds the position of Executive at Syndax Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Keith A. Goldan has shown a selling trading pattern, with $47.4K in total purchases and $120.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Keith A. Goldan was on Feb 7, 2024, when they purchased $1.6M worth of SNDX shares. This transaction involved 70,000 shares at $22.28 per share.
Keith A. Goldan currently owns 32,751 shares of Syndax Pharmaceuticals Inc (SNDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Keith A. Goldan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Keith A. Goldan has 33 Form 4 filings on record as an insider at Syndax Pharmaceuticals Inc.
Set alerts for Keith A. Goldan and 40,000+ other insiders.